Brain Cancer Trial, Recruiting NCT06894238 Sponsor: Beijing Sanbo Brain Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06894238
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are scheduled for a planned, non-emergency brain or nervous system surgery
  • People who are considered generally healthy or have only mild health conditions (as assessed by their medical team using a standard health classification system)
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

  • People who have a known neurological or psychiatric condition, such as epilepsy or Parkinson's disease
  • People who show signs of cognitive (thinking or memory) difficulties before surgery, based on a standard assessment score (confirm with trial site)
  • People who have been taking medications that affect the brain or nervous system long-term, such as antidepressants or antipsychotics
  • People who have difficulty communicating in the language used by the trial
  • People who have had a craniotomy (a type of brain surgery involving opening the skull) within the past 12 months
  • People for whom placing monitoring electrodes on the forehead and temples would not be possible — for example, due to a skin injury on the forehead, severe agitation, or because the surgical incision runs across the top of the head
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhonghua Shi, PhD,MD, Capital Medical University

Phone: 010-62856764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Sanbo Brain Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Postoperative Delirium (POD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov